W V Dörffel1, G Wallukat, G Baumann
1Department of Cardiology, Charité, University Hospital, Berlin, Germany.
Immunoadsorption (IA) improved heart function in patients with severe dilated cardiomyopathy (DCM) and autoantibodies. This pilot study suggests IA is a promising therapy for hemodynamic stabilization in advanced DCM.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: